A detailed history of Hrt Financial LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 16,722 shares of DYN stock, worth $210,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,722
Holding current value
$210,362
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$23.56 - $35.55 $393,970 - $594,467
16,722 New
16,722 $393,000
Q1 2023

May 12, 2023

BUY
$10.88 - $15.0 $235,552 - $324,750
21,650 Added 128.24%
38,532 $443,000
Q4 2022

Feb 10, 2023

BUY
$9.37 - $13.8 $158,184 - $232,971
16,882 New
16,882 $195,000

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $651M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.